Clinical Trials in Los Angeles

Showing 9861-9880 of 14,465 trials

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00058123

RATIONALE: Biological therapies such as poly-ICLC use different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This phase II trial is studying how poly-ICLC works in treating patients with recurrent, progressive, or relapsed anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins55 participantsStarted Mar 2003

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +5 more locations

COMPLETEDPhase 1/2< 1 mile

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

NCT01871805

This non-randomized, open-label, multicenter study will evaluate the safety and efficacy of alectinib in participants with ALK-rearranged non-small cell lung cancer who failed crizotinib treatment. In Phase I, cohorts of participants will receive escalating doses of alectinib orally twice daily. In Phase II, patients who failed crizotinib treatment will receive the recommended phase II dose.

Non-Small Cell Lung Cancer

Hoffmann-La Roche134 participantsStarted Sep 2013

Birmingham, Alabama, United States • Irvine, California, United States • La Jolla, California, United States +39 more locations

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Find Trials by Condition in Los Angeles

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Prospective Validation of Prostate Biomarkers for Repeat Biopsy

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Transfusion Requirements in Cardiac Surgery III

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Automated Screen for Fetal Aneuploidy